Skip to main content

Change location

You are currently on the Canada (English) website

My country is not on the list

Global

  • Bracco.com (English)

Asia

  • China (中文)
  • Japan (日本語)
  • South Korea (한국어)

Americas

  • Brazil (Português)
  • Canada (English)
  • Mexico (English)
  • Canada (Français)
  • USA (English)

Europe

  • Austria (English)
  • Belgium (English)
  • Czech Republic (English)
  • Denmark (English)
  • Finland (English)
  • France (Français)
  • Germany (Deutsch)
  • Iceland (English)
  • Italy (Italiano)
  • Luxembourg (English)
  • Norway (English)
  • Poland (English)
  • Slovakia (English)
  • Sweden (English)
  • Switzerland (English)
  • The Netherlands (English)
  • UK (English)
  • Careers
  • Media and News
  • Get in touch
    • Canada (English)
  • Home
  • we are bracco
    We are Bracco

    Welcome to a World of contrasts

    • Our businesses
    • Purpose and values
    • Our history
    • Our Foundation
    • Responsibility and Ethical conduct
  • Our Portfolio

    Proven offerings for a proven difference

    • X-ray/CT
      • Contrast agents

        • Gastrografin
        • ISOVUE
      • Fluoroscopy
        • E-Z-HD
        • E-Z-PAQUE
        • Liquid POLIBAR PLUS
        • Varibar
      • Medical devices

        • Protoco2l Touch
        • CT Exprès 3D
        • EmpowerCTA+
    • MRI
      • Contrast agents

        • MultiHance
        • ProHance
      • Medical Devices

        • EmpowerMR
    • Ultrasound
      • Contrast agents

        • SonoVue
    • Nuclear medicine
      • Contrast agents

        • Choletec
        • Kinevac
    • Interventional cardiology
      • Contrast agents

        • ISOVUE
      • Medical devices

        • ACIST CVi
        • ACIST HDi
        • ACIST RXi
    • Digital solutions
    • Oncology
    • Cardiology
  • Woman looking into microscope
    Innovation

    A deep dive into our R&D progress

    • Digital future
    • R&D
    • The Bracco sites
    • Scientific heritage and patents
  • knowledge
    Knowledge

    Current activities and future opportunities

    • E-learning
    • Partnerships in education
    • Events
  • Ceriano Laghetto
    Sustainability

    Our game plan and goals for a better world

    • Our sustainability pillars
    • Governance and transparency
    • Sustainability report
  • Our Stories
Page
Cardiology Despite the availability of effective therapies, ischaemic heart disease remains the leading cause of death around the world. Early and proper diagnosis is key to reducing cardiovascular mortality and diagnostic imaging plays a crucial role here.
A surgeon preparing for surgery.
Page
Oncology According to the World Health Organization (WHO), in 2020 cancer accounted for nearly 10 million deaths worldwide – that’s almost one in every six deaths – with cancers of the lung, colon, and rectum, and prostate being the most common.
Laboratory researcher is looking through a microscope.
Article
Talking Images podcast: The sustainable way – voices of action Talking Images podcast: The sustainable way – voices of action. What do environmental sustainability and sustainable future mean?
sustainability podcast
Product
ProHance ProHance® (gadoteridol) is a macrocyclic, non-ionic molecule chelated to a gadolinium ion, and it has a very low osmolality and viscosity.
Bracco logo
Product
Protoco2l Touch PROTOCO2LTM is a unique system that fully automates the insufflation process, freeing staff for other duties.
Bracco logo
Product
MultiHance MultiHance® is a gadolinium based MRI contrast agent, providing an increase in SNR to better visualize smaller lesions and improve the delineation of larger lesions.
Bracco logo
Product
EmpowerMR World's first hydraulic-powered MR injector eliminates batteries and associated issues.
Bracco logo
Product
Sonovue SonoVue® is a second-generation ultrasound contrast agent, designed and optimized for pressure resistance
Bracco logo
Product
ACIST CVi ACIST® Medical Systems, a Bracco Group company, develops advanced contrast injection technologies that help simplify the complexities of the cardiac cath lab.
Bracco logo
Product
ACIST RXi The ACIST RXi is the only Rapid Exchange FFR System and helps to simplify physiological assessment of complex coronary artery disease.
Bracco logo
  • Load More

The Bracco Group is an international group of highly specialized companies.
We are an active part of the healthcare sector, and a global leader in diagnostic imaging.

  • We are Bracco
  • Our Portfolio
  • Innovation
  • Knowledge
  • Sustainability
  • Our Stories
  • Pharmacovigilance
  • Data Protection

Connect with us

Via Egidio Folli 50
20134 Milan, Italy
Phone + 39 02 2177.1

  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • Imprint
  • for Bracco VPN users

Bracco Copyright © 2025 | Registered office: Via E. Folli, 50, 20134 Milano, Italy | Share Capital € 104.000.000 f.p. | VAT Milan Comp. Reg. n. 00825120157 | Milan REA n. 348182